Americas Committee for Treatment and Research in Multiple Sclerosis

Challenges of Targeting Cytokines in MS: Stephanie Blandford, MSc

March 21, 2021

The PhD candidate at the neuroimmunology laboratory at Memorial University of Newfoundland discussed the potential of interleukin-1 receptor antagonist as a biomarker in MS disability as well as a therapeutic target.